African American Women Who Receive Primary Anthracycline- and Taxane-Based Chemotherapy for Triple-Negative Breast Cancer Suffer Worse Outcomes Compared With White Women

Podobne zapisy

• Racial Disparities in the Rate of Cardiotoxicity of HER2- Targeted Therapies Among Women with Early Breast Cancer
  od: Litvak, Anya, i wsp.
  Wydane: (2018)
• The Impact of Adding Taxanes to Anthracyclines on Women with Breast Cancer Receiving Adjuvant Chemotherapy
  od: Hilaj, Erina, i wsp.
  Wydane: (2020)
• Feasibility Trial of Partial Breast Irradiation With Concurrent Dose-Dense Doxorubicin and Cyclophosphamide in Early-Stage Breast Cancer
  od: Zellars, Richard C., i wsp.
  Wydane: (2009)
• Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane
  od: Moreno-Aspitia, Alvaro, i wsp.
  Wydane: (2009)
• A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer
  od: Higgins, Michaela J., i wsp.
  Wydane: (2011)